Untitled Document

Febrile Neutropenia Virtual Journal Club

2010 Update of the EORTC Guidelines for the Use of G-CSF to Reduce the Incidence of Febrile Neutropenia

Expert perspectives with Matti Aapro, MD; Gary H. Lyman, MD, MPH, FRCP (Edin); and Ruth Pettengell, MD.

 

This independent medical education activity features an expert roundtable discussion with Matti Aapro, MD; Gary Lyman, MD, MPH, FRCP(Edin); and Ruth Pettengell, MD, and includes a downloadable reference slide deck.

The panelists briefly discuss the updated 2010 EORTC guidelines for the use of G-CSF to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumors and the rationale behind the guidelines (Aapro MS, et al. Eur J Cancer. 2010 Nov 20 [epub ahead of print]).

Support                                                          


This educational activity is supported by Amgen.


 

Featured Experts

   

Matti Aapro, MD

Clinique de Genolier

Genolier, Switzerland


 
   

Gary H. Lyman, MD, MPH, FRCP (Edin)

Duke University

Durham, North Carolina, United States

     
     

Ruth Pettengell, MD

St George’s Hospital

University of London

London, United Kingdom

Activity Date

This Webcast is available from 21 December 2010 to 21 December 2011.